W

Wave Life Sciences USA

Clinical-stage biotech developing stereopure oligonucleotides

IT Lab and GxP Systems Support Co-op

IT Service Desk & End User SupportConfirmed live in the last 24 hours
Internship · Spring 2027Lexington, MA, USAIn-person

About the Job

Requirements

  • The candidate must be enrolled in a bachelor's or master's degree program in Computer Science, Information Technology, or a related field at an accredited college or university.
  • A preferred GPA of 3.0 or higher.
  • The candidate should have a solid understanding of Windows operating systems and basic IT troubleshooting.
  • The candidate should be highly organized and able to work independently and within a team.
  • The candidate should be comfortable managing multiple responsibilities in a fast-paced, dynamic environment.
  • The candidate should have strong written and verbal communication skills.

Responsibilities

  • Provide day-to-day IT support for laboratory and GxP-regulated systems, contributing to ongoing IT projects and initiatives.
  • Collaborate with IT Technical Specialists, Business Analysts, and the IT Operations team to deliver technical solutions.
  • Manage and resolve support tickets using the FreshService platform, ensuring accurate documentation for knowledge sharing.
  • Receive hands-on training, mentorship, and guidance from senior IT team members to support learning and professional development.
  • Communicate with lab users, IT team members, and mentors about task progress, challenges, and solutions.
  • Contribute to creating and maintaining Knowledge Base articles for system upkeep and user education.
  • Participate in team meetings and contribute to process improvement initiatives.
  • Learn and apply best practices for supporting systems in a regulated GxP environment.

Desired Qualifications

  • A GPA of 3.0 or higher is preferred.

About the Company

Wave Life Sciences USA

Clinical-stage biotech developing stereopure oligonucleotides

Wave Life Sciences develops stereopure nucleic acid therapies for genetically defined diseases. Its PRISM platform designs stereopure oligonucleotides that enable RNA interference, antisense silencing, splicing modulation, and RNA editing, including AIMers that recruit ADAR enzymes to edit RNA without changing the DNA. The company funds R&D mainly through partnerships and licensing (notably with GSK) and has programs in conditions like Alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, Huntington’s disease, and obesity. Its goal is to bring approved RNA medicines to patients by advancing a diversified pipeline and sustaining long-term collaborations that fund development.

Company size
201-500
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2012

Recently Posted Jobs

Explore more opportunities at Wave Life Sciences USA

See more jobs